Lurasidone for the treatment of schizophrenia in adult and paediatric populations

Schizophrenia is a common debilitating disorder characterized by significant impairments in how reality is perceived, combined with behavioural changes. In this review, we describe the lurasidone development programme for adult and paediatric patients. Both the pharmacokinetic and pharmacodynamic ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilera, Teresa, Chart Pascual, Juan Pablo, Blasco, Maria del Carmen, Calvo Estopiñán, Pilar, Piernas González, Rubén Asensio, Ramírez Martínez, Isabel, Rodríguez Moyano, Cristóbal, Prieto Pérez, Rita, Gabarda-Inat, Irene, Prados-Ojeda, Juan L, Diaz-Marsà, Marina, Martín-Carrasco, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914098/
https://www.ncbi.nlm.nih.gov/pubmed/36793449
http://dx.doi.org/10.7573/dic.2022-10-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914098/
https://www.ncbi.nlm.nih.gov/pubmed/36793449
http://dx.doi.org/10.7573/dic.2022-10-1

Ejemplares similares